Skip to main content

Want a detailed portfolio tracker?

Kodiak Sciences (KOD) P/E (2018 - 2026)

Kodiak Sciences (KOD) P/E from Oct 4, 2018 to Jul 21, 2026. The TTM Kodiak Sciences (KOD) P/E is -10.49. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kodiak Sciences (KOD)

YearP/EChange
2026-10.49+57.48%
2025-6.66+124.26%
2024-2.97+406.34%
2023-0.59-43.81%
2022-1.04-93.63%
2021-16.38-68.23%
2020-51.56-13.24%
2019-59.44+1325.10%
2018-4.17N/A

Comparison Kodiak Sciences (KOD) P/E with competitors

Kodiak Sciences (KOD) P/E is -10.49.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.71%
FGENFibroGen Inc0.24-102.29%
CHRSCoherus Biosciences Inc0.85-108.09%
FBIOFortress Biotech Inc0.95-109.04%
ORMPOramed Pharmaceuticals Inc1.50-114.32%
AGENAgenus Inc3.01-128.68%
INVAInnoviva Inc3.15-130.05%
VXRTVaxart Inc3.55-133.82%
CRMDCorMedix Inc3.63-134.57%
CVACCureVac N.V.4.45-142.36%
GLPGGalapagos NV4.86-146.30%
SRPTSarepta Therapeutics Inc4.88-146.52%
ABEOAbeona Therapeutics Inc5.39-151.34%
ABUSArbutus Biopharma Corp5.60-153.32%
ZVRAZevra Therapeutics Inc5.89-156.10%
SPROSpero Therapeutics Inc6.23-159.35%
CGENCompugen Ltd6.31-160.16%
RIGLRigel Pharmaceuticals6.87-165.48%
SLXNSilexion Therapeutics Corp7.30-169.52%
OMEROmeros Corporation9.26-188.23%
AUPHAurinia Pharmaceuticals Inc9.58-191.33%
PLXProtalix BioTherapeutics Inc10.89-203.78%
ACADAcadia Pharmaceuticals Inc11.73-211.76%
TBPHTheravance Biopharma Inc12.26-216.84%
ADMAAdma Biologics Inc12.42-218.33%
HRMYHarmony Biosciences Holdings Inc13.82-231.69%
SABSSAB Biotherapeutics Inc14.14-234.70%
NAGENiagen Bioscience Inc14.82-241.20%
INCYIncyte Corp15.82-250.77%
REGNRegeneron Pharmaceuticals Inc15.86-251.10%
PBYIPuma Biotechnology Inc17.32-265.00%
CPRXCatalyst Pharmaceuticals Inc17.44-266.18%
EXELExelixis Inc17.54-267.12%
TGTXTG Therapeutics Inc18.97-280.73%
MDXGMimedx Group Inc20.55-295.84%
XOMAXOMA Royalty Corp22.87-317.98%
ARGXArgen X SE24.30-331.54%
CTMXCytomX Therapeutics Inc24.82-336.52%
XOMAOXOMA Royalty Corp25.34-341.51%
HALOHalozyme Therapeutics Inc25.62-344.17%
XOMAPXOMA Royalty Corp25.67-344.61%
VRTXVertex Pharmaceuticals Inc27.99-366.77%
RPRXRoyalty Pharma plc - Class A28.69-373.37%
SLNOSoleno Therapeutics Inc29.02-376.49%
ASNDAscendis Pharma A/S30.09-386.69%
LGNDLigand Pharmaceuticals Inc - Class B37.91-461.27%
APLSApellis Pharmaceuticals Inc39.02-471.84%
BMRNBiomarin Pharmaceutical Inc42.21-502.24%
KRYSKrystal Biotech Inc45.34-532.08%
ONCBeiGene Ltd69.54-762.66%
PHARPharming Group N.V.75.03-814.93%
TECHBio-Techne Corp101.96-1071.57%
VCELVericel Corp109.92-1147.45%
ALNYAlnylam Pharmaceuticals Inc117.96-1224.10%
GMABGenmab140.29-1436.85%
TLXTelix Pharmaceuticals Ltd162.15-1645.17%
CORTCorcept Therapeutics Inc212.86-2128.35%